A genetic approach to identify amino acids in Gcn1 required for Gcn2 activation

PLoS One. 2022 Nov 28;17(11):e0277648. doi: 10.1371/journal.pone.0277648. eCollection 2022.

Abstract

The protein kinase Gcn2 is present in virtually all eukaryotic cells. It is best known for its role in helping cells cope with amino acid starvation. Under starvation, Gcn2 phosphorylates the α subunit of the eukaryotic translation initiation factor 2 (eIF2α), to stimulate a signal transduction pathway that allows cells to cope and overcome starvation. Gcn2 has been implicated in many additional biological functions. It appears that for all functions, Gcn2 must directly bind to its effector protein Gcn1, mediated via a region in Gcn1 called the RWD binding domain (RWDBD). Arg-2259 in this region is important for Gcn2 binding. Overexpression of a Gcn1 fragment only encompassing the RWDBD binds Gcn2, thereby disrupting endogenous Gcn1-Gcn2 interaction which dampens Gcn2 activation. Consequently, cells are unable to increase eIF2α phosphorylation under starvation conditions, visible by impaired growth. This dominant negative phenotype is reverted by the R2259A substitution, again allowing Gcn1-Gcn2 interaction and enhanced eIF2α phosphorylation. We have found that the amino acid substitutions, R2289A, R2297A, and K2301A, also reverted the dominant negative phenotype as well as allowed enhanced eIF2α phosphorylation, as found previously for the R2259A substitution. This suggests that the respective amino acids are relevant for the overexpressed RWDBD to disrupt Gcn1-Gcn2 interaction and impair Gcn2 activation, supporting the idea that in Gcn1 these amino acids mediate Gcn2-binding. Our findings suggest that two helices in Gcn1 constitute a Gcn2 binding site. We serendipitously found amino acid substitutions that enhanced the dominant negative phenotype that correlated with a further reduction in eIF2α-P levels, suggesting that the respective RWDBD variants are more potent in disrupting Gcn1-Gcn2 interaction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Substitution
  • Amino Acids
  • Eukaryotic Initiation Factor-2 / genetics
  • Peptide Elongation Factors* / genetics
  • Peptide Elongation Factors* / metabolism
  • Protein Serine-Threonine Kinases* / genetics
  • Protein Serine-Threonine Kinases* / metabolism
  • RNA-Binding Proteins / metabolism
  • Saccharomyces cerevisiae
  • Saccharomyces cerevisiae Proteins* / genetics
  • Saccharomyces cerevisiae Proteins* / metabolism
  • Trans-Activators / metabolism

Substances

  • Amino Acids
  • Eukaryotic Initiation Factor-2
  • GCN1 protein, S cerevisiae
  • GCN2 protein, S cerevisiae
  • Peptide Elongation Factors
  • Protein Serine-Threonine Kinases
  • RNA-Binding Proteins
  • Saccharomyces cerevisiae Proteins
  • Trans-Activators

Grants and funding

This research was supported by the New Zealand Health Research Council breast cancer partnership programme and by funds from Massey University Foundation donors Bryce Carmine and Ann (née Percival) Carmine. SG was supported by a Massey University PhD scholarship and by the School of Natural Sciences.